Nature rejected her paper for not being original, University of Pennsylvania (her employer) demoted her, and yesterday Katalin Karikó won the Noble Prize in physiology. In mid-2000s, Karikó and her Drew Weismann submitted their paper on mRNA (messenger Ribonucleic Acid) to

Bank Security 1: No one needs your pin to withdraw money from your bank, all that is needed is 5 sec access to your VISA card. On your VISA card, all that is needed online to withdraw money is the card number, expiration date, name on card and CVC code. These, if someone has 5

Dear Global Family, friends & colleagues; Am inviting you to support me to get much needed Bone Marrow Transplants for my daughters Gloria and Moriah scheduled for Jan2024 in India.

“PrEP uptake is higher at facilities were all 3 options (oral, ring, and CAB PrEP) are available” Hasina Subedar from South Africa’s DoH #HIVR4P2024

Project PrEP’s DCE on service delivery preferences showed a strong preference for decntralized and pharmacy PrEP pick up points. #HIVR4P2024

“Young people bring a unique perspective, they are more than just a statistic!” Zambia’s Chilufya Kasanda Hampongo explains the role of youth advocates as advisors in clinical research at the #HIVR4P2024

Are we meaningfully engaging the youth in HIV prevention research? We need to: Invest in youth leadership Foster participation Co-design studies Step back & let them lead Amplify their voices! #YouthEmpowerment #HIVR4P2024"

“mHealth tools can support young women’s education and decision making regarding their sexual and reproductive health” says Florida State University’s Kate Muessig at #HIVR4P2024. The Vuka App, for example is supporting adherence to PrEP and providing health and wellness information

“Sociobehavioral scientists are often treated as step-children and often encounter closed doors in research” says IAVI-Kenya’s Kapellah at the SBR plenary session at #HIVR4P2024. We need more advocacy to ensure interdisciplinary collaboration between SBR & biomedical science!

At the Manifest CHOICE session at the #HIVR4P2024, we learnt: • There is no - and never will be - a miracle PrEP drug • Advocate for CHOICE and not for individual products • PrEP choice rollout is feasible but challenges and access gaps remain

Building on success plenary at the #HIVR4P2024 highlighted: • Epidemic control by 2030 is unlikely with the current scale up of HIV prevention strategies • PrEP choice is complex and dynamic • Pleasure interventions increase condom use and sexual health outcomes

“It’s an exciting time to be alive” says Linda-Gail Bekker after the novel antiretrovirals and formulations for prevention session at #HIVR4P2024. Breakthrough studies: • TFV Douche • IMPOWER 22/24 (ISL) • Dual regimen for U=U • LA silica hydrogel depot • PURPOSE 2 (LEN)

At #HIVR4P2024’s prevention product profile session today, we were delighted to learn: • Pipeline products to prevent HIV & pregnancy upto 2years! • Choice also applies to service delivery • Speak young people’s language • Engage advocates as advisors in clinical research

“Oral PrEP maybe be altering the vaginal microbiota of pregnant women and predisposing them to the risk of preterm birth. A larger study is needed to confirm the findings.” says Friday Saidi from the UNC Project - Malawi at #HIVR4P2024

Exciting HIV prevention science at the late-breaker abstracts at #HIVR4P2024: •PK superiority of the 3mthly 100mg PrEP ring •Acceptability of LA PrEP placebos •LAI-CAB continuum •HIV RDTs for CAB-LA •WGS and HIV prevalence gender-gap •Estimating HIV acquisition time

To reduce barriers to use of HIV prevention options, we need to: • Counter misinformation with effective communication • Focus less on risk and more on pleasure • Implement a pleasure-centered approach for Chemsex #HIVR4P2024

“74% of women were very likely or likely to use a non-hormonal MPT vaginal ring that prevents HIV, pregnancy, bacterial vaginosis, and other STIs with moderate efficacy, which is under development” says Population Council’s @SanyuktaMathur at #HIVR4P2024

“40% of women prefer the dual prevention pill (DPP) compared to taking PrEP and COCs separately suggesting a market for this product. Women who engaged in transactional sex and had multiple partners are more likely to prefer the DPP.” Population Council’s B Zieman at #HIVR4P2024

Back from #HIVR4P2024 in Lima! • Inspired by groundbreaking HIV prevention science • Connected with amazing mentors & global colleagues • Forged lifelong friendships Can't wait for #AIDS2025 in Kigali, Rwanda, July 2025! #HIVPrevention #GlobalHealth #ResearchForImpact

Extremely grateful to present our MOSAIC Consortium poster at #IAS2025 in Kigali! ✨ Conference highlights: 💉 WHO recommends LEN for PrEP 💊 MK-8527 monthly pill moves to Phase 3 💰 Protect #HIV funding ✊🏿 Advocates: “We will not be erased!” See you in Rio 🇧🇷 for #AIDS2026!